JAR-Labs
Tel. +852 3943-6789
  • JAR-Labs
  • Emesis
    • Assessing 'Nausea'
  • GI Dysrhythmia
    • Shrew Model
    • Ferret Model
    • Mouse Model
    • Zebrafish Model
  • Alzheimer's Disease
    • Non-transgenic GI-seeded Beta-amyloid Model
  • MEA
    • Gastrointestinal
    • Acute Brain Slices
  • People
    • Dr. Z. Lu
    • Julia YH Liu
    • Jessica CM Hui
    • KHALID Aleena
    • Lingqing Yang
    • Nora, Luping LIU
    • Heidi HS Ng
    • Kate, Zitong LI
    • Sam D Cui
    • Yingyi Deng
    • M.P. Ngan
    • Former members >
      • Jiang Bin
      • Jacky Chiu Yeung, TSANG
      • Varsha Suresh
      • Charmaine JS Kung
      • Ianto B. Huang
      • Sun Yayi
      • Tu Longlong
      • Dr. R.N. Sommerville
      • H.C.E. Wang
  • Publications
  • Gut Rhythm (Start-up)

Lingqing YANG​

MPhil-PhD 2020 - Present

Email
  • ​I graduated from BSc Biomedical Engineering in the Hunan University.
  • Currently, I’m pursuing a PhD degree in the School of Biomedical Sciences, the Chinese University of Hong Kong.
  • My research project is about the action of ghrelin to prevent chemotherapy-induced side effects in Suncus murinus (house musk shrew)

Research Interests

  • Ghrelin has well-known appetite stimulating properties, gastric prokinetic activity, and short acting anti-emetic affects against cisplatin-induced emesis in ferrets.
  • However, clear anti-emetic effects are only seen following intracerebroventricular (i.c.v.) administration.
  • Our previous study showed ghrelin and ghrelin mimetics could antagonize the early emesis induced by the chemotherapeutic drug, cisplatin.
  • There are two naturally occurring forms of ghrelin: acyl-ghrelin (AG) and des-acyl-ghrelin (DAG).
  • In the present studies, we investigate if both forms of ghrelin can reduce the early and delayed emesis and associated side-effects induced by cisplatin in Suncus murinus following an administration into the brain.